Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
Kidney International. Supplement|July 21, 1999
Atherogenic lipoproteins, oxidative stress, and cell deathJ Galle, K Heermeier, C WannerThe Journal of Laboratory and Clinical Medicine|November 1, 1995
Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cellsR Hirschberg, H Ding, C WannerEuropean Heart Journal|November 1, 1993
Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endotheliumJ Galle, P Schollmeyer, C WannerEuropean Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 22, 2008
Nomen est omen. Fabry diseaseF Weidemann, C Wanner, F BreunigThe International Journal of Artificial Organs|April 1, 1994
Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study GroupP Kulzer, R M Schaefer, R Krahn, et al.The Journal of Laboratory and Clinical Medicine|September 1, 1986
Urinary proteinase activity in patients with multiple traumatic injuries, sepsis, or acute renal failureC Wanner, P Schollmeyer, W H HörlMetabolism: Clinical and Experimental|March 1, 1988
Serum carnitine levels and carnitine esters of patients after kidney transplantation: role of immunosuppressionC Wanner, P Schollmeyer, W H HörlBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Use of HMG-CoA Reductase Inhibitors after Kidney and Heart Transplantation: Lipid-Lowering and Immunosuppressive EffectsC Wanner, A Krämer-Guth, J GalleClinical Nephrology|April 1, 1990
Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosusK W Dreyling, C Wanner, P SchollmeyerMetabolism: Clinical and Experimental|July 1, 1997
Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)--but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)]--in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptorW Bartens, A Krämer-Guth, C WannerPageof 18